Literature DB >> 20238059

Protection of photoreceptors in a mouse model of RP10.

Lawrence C S Tam1, Anna-Sophia Kiang, Naomi Chadderton, Paul F Kenna, Matthew Campbell, Marian M Humphries, G Jane Farrar, Pete Humphries.   

Abstract

Recombinant adeno-associated viral (rAAV) vectors have recently been widely used for the delivery of therapeutic transgenes in preclinical and clinical studies for inherited retinal degenerative diseases. Interchanging capsid genes between different AAV serotypes has enabled selective delivery of transgene into specific cell type(s) of the retina. The RP10 form of autosomal dominant retinitis pigmentosa (adRP) is caused by missense mutations within the gene encoding inosine 5'-monophosphate dehydrogenase type 1. Here, we report that the use of rAAV2/5 vectors expressing shRNA targeting mutant IMPDH1 prevents photoreceptor degeneration, and preserves synaptic connectivity in a mouse model of RP10.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238059     DOI: 10.1007/978-1-4419-1399-9_64

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Gene delivery to the retina: from mouse to man.

Authors:  Jean Bennett; Daniel C Chung; Albert Maguire
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

2.  RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

Authors:  Pavitra S Ramachandran; Sajag Bhattarai; Pratibha Singh; Ryan L Boudreau; Stewart Thompson; Albert R Laspada; Arlene V Drack; Beverly L Davidson
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.